Evidence map›Paper›PMID 30025524›Full record

SynthesisBMC medicine2018

The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses.

Myrela O Machado, Nicola Veronese, Marcos Sanches, Brendon Stubbs, Ai Koyanagi, Trevor Thompson, Ioanna Tzoulaki, Marco Solmi, Davy Vancampfort, Felipe B Schuch and 4 more

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMC medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04234776 (Intramuscular Ketamine Versus Escitalopram and Aripiprazole in Acute and Maintenance Treatment of Patients With Treatment-resistant Depression), which is not on this map. Cited by 113 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 11 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04234776 phase4unknown statusnot on this map

Intramuscular Ketamine Versus Escitalopram and Aripiprazole in Acute and Maintenance Treatment of Patients With Treatment-resistant Depression

TypeinterventionalSponsorUniversity of Sao PauloRan2018 to 2021Enrolled88ConditionsDepressive DisorderArmsKetamine, Cognition, Suicide risk, Depression thoughts, Quality of life and disability
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 11 syntheses or guidelines pooled it, 262 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Depressive symptom heterogeneity and mortality in a prospective U.S. cohort.European archives of psychiatry and clinical neuroscience · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 14 institutions in 10 countries.

Myrela O MachadoDepartment of Clinical Medicine and Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, 60430-140, Brazil.
Nicola VeroneseInstitute for Clinical Research and Education in Medicine (IREM), 35128, Padova, Italy.
Marcos SanchesBiostatistical Consulting Unit, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Brendon StubbsInstitute for Clinical Research and Education in Medicine (IREM), 35128, Padova, Italy.
Ai KoyanagiParc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu/CIBERSAM, 08950, Barcelona, Spain.
Trevor ThompsonFaculty of Education and Health, University of Greenwich, London, SE10 9LS, UK.
Ioanna TzoulakiDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, W2 1PG, London, UK.
Marco SolmiInstitute for Clinical Research and Education in Medicine (IREM), 35128, Padova, Italy.
Davy VancampfortDepartment of Rehabilitation Sciences, KU Leuven - University of Leuven, 3001, Leuven, Belgium.
Felipe B SchuchCentro Universitário La Salle, Canoas, Brazil.
Michael MaesDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.
Giovanni A FavaDepartment of Psychology, University of Bologna, viale Berti Pichat 5, 40127, Bologna, Italy.
John P A IoannidisDepartment of Medicine, Stanford University, Palo Alto, CA, 94305, USA.
André F CarvalhoDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada. andre.carvalho@camh.ca.
Centre for Addiction and Mental Health · CAChulalongkorn University · THErie County Medical Center · USImperial College London · GBKing's College London · GBKU Leuven · BENeuroscience Institute · ITParc Sanitari Sant Joan de Déu · ESStanford University · USUniversidade Federal do Ceará · BRUniversidade La Salle · BRUniversity of Greenwich · GBUniversity of Padua · ITUniversity of Toronto · CA

Funding

Department of Health ICA-CL-2017-03-001
6 · The paper itself

Abstract

backgroundDepression is a prevalent and disabling mental disorder that frequently co-occurs with a wide range of chronic conditions. Evidence has suggested that depression could be associated with excess all-cause mortality across different settings and populations, although the causality of these associations remains unclear.

methodsWe conducted an umbrella review of systematic reviews and meta-analyses of observational studies. PubMed, PsycINFO, and Embase electronic databases were searched through January 20, 2018. Systematic reviews and meta-analyses that investigated associations of depression and all-cause and cause-specific mortality were selected for the review. The evidence was graded as convincing, highly suggestive, suggestive, or weak based on quantitative criteria that included an assessment of heterogeneity, 95% prediction intervals, small-study effects, and excess significance bias.

resultsA total of 26 references providing 2 systematic reviews and data for 17 meta-analytic estimates met inclusion criteria (19 of them on all-cause mortality); data from 246 unique studies (N = 3,825,380) were synthesized. All 17 associations had P < 0.05 per random effects summary effects, but none of them met criteria for convincing evidence. Associations of depression and all-cause mortality in patients after acute myocardial infarction, in individuals with heart failure, in cancer patients as well as in samples from mixed settings met criteria for highly suggestive evidence. However, none of the associations remained supported by highly suggestive evidence in sensitivity analyses that considered studies employing structured diagnostic interviews. In addition, associations of depression and all-cause mortality in cancer and post-acute myocardial infarction samples were supported only by suggestive evidence when studies that tried to adjust for potential confounders were considered.

conclusionsEven though associations between depression and mortality have nominally significant results in all assessed settings and populations, the evidence becomes weaker when focusing on studies that used structured interviews and those that tried to adjust for potential confounders. A causal effect of depression on all-cause and cause-specific mortality remains unproven, and thus interventions targeting depression are not expected to result in lower mortality rates at least based on current evidence from observational studies.

Indexed as

Cause of DeathDepressionHumansMeta-Analysis as TopicObservational Studies as TopicSurvival RateSystematic Reviews as TopicAll-causeCause-specificDepressionMeta-analysesMortalityPsychiatrySurvivalSystematic reviewsUmbrella review

Identifiers

PMID30025524
PMCPMC6053830
OpenAlexW2810894650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.